Superficial fungal infections: Errors to avoid in diagnosis and treatment

Postgraduate Medicine

Volumn 101, Issue 4, 1997, Pages 279-287

  Brodell, Robert T ^a   Elewski, Boni ^b  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CEFAZOLIN; ECONAZOLE; FLUCONAZOLE; GRISEOFULVIN; ITRACONAZOLE; KETOCONAZOLE; POTASSIUM HYDROXIDE; SELENIUM SULFIDE; TERBINAFINE;

ADULT; AGED; CELLULITIS; CHILD; CLINICAL ARTICLE; FEMALE; HAIR DISEASE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MYCOSIS; ONYCHOMYCOSIS; ORAL DRUG ADMINISTRATION; REVIEW; TINEA VERSICOLOR; TOPICAL DRUG ADMINISTRATION; TRICHOPHYTON;

ADULT; AGED; ANIMALS; ANTIFUNGAL AGENTS; CATTLE; CHILD; DERMATOMYCOSES; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NAIL DISEASES; PSORIASIS; TINEA;

EID: 0030904049     PISSN: 00325481     EISSN: 19419260     Source Type: Journal    
DOI: 10.3810/pgm.1997.04.209     Document Type: Article

References (29)

1. Gupta AK, Sauder DN, Shear NH. Antifungal agents: an overview. Part II. J Am Acad Dermatol 1994; 30 (6): 911 – 33
2. Gupta AK, Sauder DN, Shear NH. Antifungal agents: an overview. Part I. J Am Acad Dermatol 1994; 30 (5 Pt 1): 677 – 98
3. Elewski BE. Clinical pearl: diagnosis of onychomycosis. J Am Acad Dermatol 1995; 32 (3): 500 – 1
4. Brodell RT, Helms SE, Snelson ME. Office dermatologic testing: the KOH preparation. Am Fam Physician 1991; 43 (6): 2061 – 5
5. Halasz CL. Successful treatment with fluconazole of tinea corporis caused by Trichophyton verrucosum (barn itch). Cutis 1994; 54 (3): 207 – 8
6. Roberts SO. Pityriasis versicolor: a clinical and mycological investigation. Br J Dermatol 1969; 81 (5): 315 – 26
7. Faergemann J, Fredriksson T. Tinea versicolor: some new aspects on etiology, pathogenesis, and treatment. Int J Dermatol 1982 Jan-Feb; 21 (1): 8 – 11
8. Faergemann J, Fredriksson T. Age incidence of Pityrosporum orbiculare on human skin. Acta Derm Venereol 1980; 60 (6): 531 – 3
9. Martin AG, Kobayashi GS. “Pityrosporum infections” of the skin: papulosquamous tinea versicolor, “Pityrosporum” folliculitis, and inverse tinea versicolor. In: Fitzpatrick TB, Eisen AZ, Wolff K, et al, eds. Dermatology in general medicine. Vol 2. 4th ed. New York: McGraw-Hill, 1993: 2462 – 7
10. Guidelines/Outcomes Committee of the American Academy of Dermatology. Guidelines of care for superficial mycotic infections of the skin: Pityriasis (tinea) versicolor. J Am Acad Dermatol 1996; 34 (2 Pt 1): 287 – 9
11. Schwartz RA, Janniger CK. Tinea capitis. Cutis 1995; 55 (1): 29 – 33
12. Elewski BE. Tinea capitis: itraconazole in Trichophyton tonsurans infection. J Am Acad Dermatol 1994; 31 (1): 65 – 7
13. Kelley L, Howard R, Frieden IJ. Tinea capitis: diagnosis and treatment. Fitzpatrick's J Clin Dermatol 1994;Jul/Aug: 43 – 6
14. Ginsburg CM, McCracken GH Jr, Petruska M, et al. Effect of feeding on bioavailability of griseofulvin in children. J Pediatr 1983; 102 (2): 309 – 11
15. Babel DE, Baughman SA. Evaluation of the adult carrier state in juvenile tinea capitis caused by Trichophyton tonsurans. J Am Acad Dermatol 1989; 21 (6): 1209 – 12
16. Guidelines/Outcomes Committee of the American Academy of Dermatology. Guidelines of care for superficial mycotic infections of the skin: Onychomycosis. J Am Acad Dermatol 1996; 34: 116 – 21
17. Shear NH, Gupta AK. Terbinafine for the treatment of pedal onychomycosis: a foot closer to the promised land of cured nails? Arch Dermatol 1995; 131 (8): 937 – 42
18. Kuokkanan K, Alava S. Fluconazole in the treatment of onychomycosis caused by dermatophytes. J Dermatol Treat 1992; 3: 115 – 7
19. Roseeuw D, De Doncker P. New approaches to the treatment of onychomycosis. J Am Acad Dermatol 1993; 29 (1): S45 – 50
20. Hochman LG, Scher RK, Meyerson MS, et al. The safety and efficacy of oral fluconazole in the treatment of onychomycosis. J Geriatr Dermatol 1993; 1 (4): 169 – 72
21. Matthieu L, De Doncker P, Cauwenbergh G, et al. Itraconazole penetrates the nail via the nail matrix and the nail bed- an investigation in onychomycosis. Clin Exp Dermatol 1991; 16 (5): 374 – 6
22. De Doncker P, Decroix J, Pierard GE, et al. Antifungal pulse therapy for onychomycosis: a pharmacokinetic and pharmacodynamic investigation of monthly cycles of 1-week pulse therapy with itraconazole. Arch Dermatol 1996; 132 (1): 34 – 41
23. Kates SG, Nordstrom KM, McGinley KJ. Microbial ecology of interdigital infections of toe web spaces. J Am Acad Dermatol 1990; 22 (4): 578 – 82
24. Brodell JD, Brodell RT. Recurrent lymphangitic cellulitis syndrome. Contemp Orthopaed 1992; 25 (5): 461 – 8
25. Leyden JJ. Progression of interdigital infections from simplex to complex. J Am Acad Dermatol 1993; 28 (5 Pt 1): S7 – 11
26. Brodell RT, Elewski BE. Clinical pearl: systemic antifungal drugs and drug interactions. J Am Acad Dermatol 1995; 33: 259 – 60
27. Brodell RT, Elewski BE. Systemic antifungal drugs and drug interactions. (Letter) J Am Acad Dermatol 1995; 35 (1): 135
28. Grevelink S, Fitzpatrick TB. Drug interactions. I. Antifungals. Fitzpatrick's J Clin Dermatol 1994;Nov/Dec: 57
29. Martin AG, Kobayashi GS. Tinea cruris. In: Fitzpatrick, et al, eds,' pp 2436 – 7